← SynDRA
FEXOFENADINE
SynDRA canonical compound SYN0002538 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HRH1 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
| Indication | allergic rhinitis | urticaria |
|---|
| Disease area | allergy |
|---|
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Drug classes
- Histamine H1 Receptor Antagonists
- Histamine-1 Receptor Antagonist
- Anti-Allergic Agents
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Histamine H1 Antagonists, Non-Sedating
- Neurotransmitter Agents
ATC classes
- R06A · ANTIHISTAMINES FOR SYSTEMIC USE
Cross-references
Synonyms
- terfenadine carboxylate
- fexofenadine hydrochloride
- fexofenadine HCl
- Fexofenadina
- Telfast
- Carboxyterfenadine
- Fexofendine
- Terfenadine acid metabolite
- Terfenadine carboxylate
- F 9427
- MDL 16455
- Allegra (TN)
- Fastofen (TN)
- Fexofenadine (INN)
- Fexofenadine [INN:BAN]
- Telfast (TN)
- Terfenadine-COOH
- Terfenidine carboxylate, MDL 16455
- Tilfur (TN)
- 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid
- 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid
- 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid
- E6582LOH6V
- fexofenadine (usp-rs)
- MDL-16455
- CHEBI:5050
- fexofenadinum
- RefChem:5830
- DTXCID50197277
- R06AX26
- Allegra
- MDL-16455; Terfenadine carboxylate
- S-FEXOFENADINE
- FEXOFENADINE [INN]
- HSDB 7486
- NCGC00015453-05
- UNII-E6582LOH6V
- SR-01000075889
Reported adverse events
- Cough
- Dizziness
- Fatigue
- Headache
- Pain in extremity
- Pain
- Dyspepsia
- Myalgia
- Nasopharyngitis
- Nausea
- Pyrexia
- Somnolence
Look up FEXOFENADINE in the interactive SynDRA portal →